Primary Site >> Biliary tract Cancer

Gene >> STMN1

  • 1985
  • 2009
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
Ref: No evidence of association between methyldopa and biliary carcinoma.
PMID: 3988445
 Ref: Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened.
PMID: 19582585
 Ref: Atypical presentation of an advanced obstructive biliary cancer without jaundice.
PMID: 24223234
 Ref: Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
PMID: 24708177
Ref: [From recognition to practice: The 140th anniversary of the discovery of Clonorchis sinensis].
PMID: 25518585
 Ref: Risk of bile duct cancer among printing workers exposed to 1,2-dichloropropane and/or dichloromethane.
PMID: 25739336
 Ref: High expression of karyopherin-alpha2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction.
PMID: 27338241
Ref: Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo.
PMID: 27349455
Ref: Relationship between cumulative exposure to 1,2-dichloropropane and incidence risk of cholangiocarcinoma among offset printing workers.
PMID: 27371662
Ref: miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
PMID: 27577078
 Ref: Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling.
PMID: 28178656
Ref: Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.
PMID: 29312550